|
Volumn 13, Issue 12, 2010, Pages 840-842
|
Biological therapeutics research and development-GTCbio's fifth annual conference
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOVIRUS VECTOR;
AVIPOX VACCINE;
B7 ANTIGEN;
BHT 3009;
BHT 3021;
BHT 3034;
CANCER VACCINE;
DNA VACCINE;
ETBX 011;
GAMMA INTERFERON;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INFLUENZA VACCINE;
INTERCELLULAR ADHESION MOLECULE 1;
INTERLEUKIN 2;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;
MACROGOL;
MUCIN 1;
OBATOCLAX;
PROSTATE SPECIFIC ANTIGEN ENCODING VACCINE;
RG 7426;
SAMARIUM 153;
SUNITINIB;
TG 4010;
UNCLASSIFIED DRUG;
ABSENCE OF SIDE EFFECTS;
ANTIGEN PRESENTATION;
AUTOIMMUNE DISEASE;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER IMMUNIZATION;
CELLULAR IMMUNITY;
COLON CANCER;
CONFERENCE PAPER;
CYTOTOXIC T LYMPHOCYTE;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SAFETY;
HUMAN;
INFLUENZA A (H1N1);
INSULIN DEPENDENT DIABETES MELLITUS;
LUNG NON SMALL CELL CANCER;
MALIGNANT NEOPLASTIC DISEASE;
MULTIPLE SCLEROSIS;
MYASTHENIA GRAVIS;
NATURAL KILLER CELL;
NONHUMAN;
OVERALL SURVIVAL;
PROSTATE CANCER;
PROTEIN EXPRESSION;
TREATMENT RESPONSE;
ANIMALS;
ANTIGENS, NEOPLASM;
AUTOIMMUNE DISEASES;
BIOLOGICAL PRODUCTS;
CANCER VACCINES;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
LUNG NEOPLASMS;
PEPTIDES;
VACCINES, COMBINED;
VACCINES, DNA;
|
EID: 79952770454
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (1)
|
References (0)
|